Keywords: sankyo, full-year, revenues, rise, japan, revised, its
Sankyo's full-year revenues rise 4.6%
Article | 07 June 2004
Japan's Sankyo has revised its original fiscal year to March 2005 forecast, following higher-than-expected results on exports of the cholesterol-lowerer Pravachol/ ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
